Boosting liquidity and investment through stake sale
- Capita to sell its 75% stake in Fera Science to Bridgepoint Group
- Sale completes Capita’s noncore disposal program
- Enterprise value of £60 million ($76.3 million)
- Sale will provide additional liquidity and support investment across the group
- Fera Science specializes in environmental testing, research, and advisory services
Capita has agreed to sell its 75% stake in Fera Science to Bridgepoint Group for an enterprise value of £60 million ($76.3 million), completing its noncore disposal program. The sale will provide additional liquidity to boost Capita’s balance sheet and support investment across the group. Fera Science specializes in environmental testing, research, and advisory services for both the public and private sectors. All senior management and employees will remain with the business.
Public Companies: Capita (unknown)
Private Companies: Fera Science, Bridgepoint Group
Key People: Michael Susin (unknown)
Factuality Level: 9
Justification: The article provides factual information about Capita selling its stake in Fera Science to Bridgepoint Group for an enterprise value of 60 million pounds. It also mentions that the sale will provide additional liquidity to boost Capita’s balance sheet and support investment across the group. The article states that Fera specializes in environmental testing, research, and advisory and assurance services for both the public and private sectors, and that all senior management and employees will remain with the business. There are no digressions, misleading information, sensationalism, redundancy, or opinion masquerading as fact in the article.
Noise Level: 7
Justification: The article provides basic information about Capita’s sale of its stake in Fera Science to Bridgepoint Group. However, it lacks in-depth analysis, evidence, and actionable insights. It stays on topic and provides some information about Fera’s specialization, but overall, it is a relatively short and straightforward news article without much depth or critical analysis.
Financial Relevance: Yes
Financial Markets Impacted: The sale of Capita’s stake in Fera Science may impact Capita’s financial position and balance sheet.
Presence of Extreme Event: No
Nature of Extreme Event: No
Impact Rating of the Extreme Event: No
Justification: The article discusses a financial transaction involving Capita selling its stake in Fera Science. There is no mention of any extreme event or its impact.
www.marketwatch.com 
